daunorubicin has been researched along with mk 2206 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Q; Han, J; Jin, R; Zhang, M; Zhou, F | 1 |
1 other study(ies) available for daunorubicin and mk 2206
| Article | Year |
|---|---|
Ikaros 6 protects acute lymphoblastic leukemia cells against daunorubicin-induced apoptosis by activating the Akt-FoxO1 pathway.
Topics: Apoptosis; Cell Line, Tumor; Child; Cytoprotection; Daunorubicin; Enzyme Activation; Female; Forkhead Box Protein O1; Gene Silencing; Heterocyclic Compounds, 3-Ring; Humans; Ikaros Transcription Factor; Male; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-akt; Signal Transduction | 2017 |